Central lab for virus and cancer testing in people living with HIV
Official title: Central Laboratory Core
Funded at H. Lee Moffitt Cancer Ctr & Res Inst · NIH-11414777 · Data updated 2026-11-12
This project collects and stores blood and tissue samples and runs virus and immune tests to help researchers learn more about cancer in people living with HIV.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | H. Lee Moffitt Cancer Ctr & Res Inst NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project start | August 3, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $77,837 |
| NIH project number | 3U54CA277834-03S1 |
| Project ID | NIH-11414777 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people living with HIV who have cancer (or are enrolled in partner studies) and are willing to donate blood or tissue samples at participating clinics.
✕Less likely to help
People who do not have HIV, who are not treated at participating sites, or who are unwilling or unable to donate samples are unlikely to benefit directly from this effort.
What this research studies
You may be asked to provide blood or tumor tissue samples that will be stored in a central biobank and linked to clinical information. The central lab will run standardized virus and immune system tests and provide pathology review so results are comparable across sites. Labs in South Africa, Zimbabwe, the US, and Germany will work together so samples from different countries are analyzed the same way. The core supports multiple research projects and future pilot studies aimed at improving cancer care for people with HIV.
Why it matters
Potential benefit: If successful, this work could speed development of better prevention strategies and cancer treatments tailored for people living with HIV by improving how we study tumors and immune responses.
How similar studies have gone: Biobanking and centralized lab testing have helped advance understanding of HIV-associated cancers before, and this core expands that approach with broader international coordination.
Where this research is happening
-
H. Lee Moffitt Cancer Ctr & Res Inst
Tampa, United States Active
Researchers
- Principal investigator: Schneider, Johann Wilhelm — H. Lee Moffitt Cancer Ctr & Res Inst
- Study coordinator: Schneider, Johann Wilhelm
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.